Literature DB >> 24434362

Diagnosis and classification of IgA nephropathy.

Hsin-Hui Yu1, Bor-Luen Chiang2.   

Abstract

IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide. The diagnostic hallmark of IgAN is the predominance of IgA deposits in the glomerular mesangium. The natural history of IgAN is variable. Clinical features including heavy proteinuria, elevated serum creatinine level, hypertension at presentation, and advanced histologic findings can strongly predict the risk of progressive chronic kidney disease. This article reviews the evolving history of diagnostic criteria of IgAN and the controversial aspects of the Oxford Classification. To date, there is no disease-targeted treatment for IgAN. Advances in understanding of the pathogenesis may help with earlier diagnosis and better monitoring of the treatment response and clinical course, and in the development of targeted therapy in the future.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24434362     DOI: 10.1016/j.autrev.2014.01.030

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

1.  Comparative proteomic analysis of renal tissue in IgA nephropathy with iTRAQ quantitative proteomics.

Authors:  Weiguo Sui; Zhenzhen Cui; Ruohan Zhang; Wen Xue; Minglin Ou; Guimian Zou; Jiejing Chen; Yong Dai
Journal:  Biomed Rep       Date:  2014-07-23

2.  Genetic Variation in miR-146a Is Not Associated with Susceptibility to IgA Nephropathy in Adults from a Chinese Han Population.

Authors:  Bin Yang; Wei Wei; Yunying Shi; Zhuochun Huang; Bei Cai; Junlong Zhang; Binwu Ying; Lanlan Wang
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

3.  Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study.

Authors:  Yanhong Yuan; Xiajing Che; Zhaohui Ni; Yifei Zhong; Yinghui Qi; Xinghua Shao; Qin Wang; Liou Cao; Minfang Zhang; Yuanyuan Xie; Chaojun Qi; Lei Tian; Shan Mou
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

4.  Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study.

Authors:  Xi Yang; Ri-Bao Wei; Yang Wang; Ting-Yu Su; Qing-Ping Li; Ting Yang; Meng-Jie Huang; Kun-Ying Li; Xiang-Mei Chen
Journal:  Med Sci Monit       Date:  2017-02-06

5.  Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review.

Authors:  Katie Kerr; Helen McAneney; Cheryl Flanagan; Alexander P Maxwell; Amy Jayne McKnight
Journal:  BMC Nephrol       Date:  2019-08-16       Impact factor: 2.388

6.  Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.

Authors:  Xiaofang Hu; Jie Du; Yuhong Xie; Qiong Huang; Yi Xiao; Juan Chen; Siyuan Yan; Zhicheng Gong; Shaxi Ouyang
Journal:  BMC Nephrol       Date:  2020-03-13       Impact factor: 2.388

7.  A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy.

Authors:  Li Tan; Yi Tang; Gaiqin Pei; Zhengxia Zhong; Jiaxing Tan; Ling Zhou; Dongmei Wen; David Sheikh-Hamad; Wei Qin
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

8.  Chemokine (C-C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children.

Authors:  Yanjie Shen; Zhiqing Zhu; Rui Wang; Lili Yan; Shuaichen Sun; Ling Lu; Zhenhua Ren; Qin Zhang
Journal:  BMC Nephrol       Date:  2022-06-20       Impact factor: 2.585

9.  Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.

Authors:  Zhaohui Ni; Yanhong Yuan; Qin Wang; Liou Cao; Xiajing Che; Minfang Zhang; Yuanyuan Xie; Chaojun Qi; Shan Mou
Journal:  J Transl Med       Date:  2014-07-10       Impact factor: 5.531

10.  IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case report.

Authors:  Bokki Min; Gyuree Kim; Taesun Kang; Chungsik Yoon; Sung-Il Cho; Domyung Paek
Journal:  Ann Occup Environ Med       Date:  2016-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.